https://doi.org/10.4081/monaldi.2026.4003
Divergent temporal trajectories of adiponectin and leptin in critically ill patients with COVID-19-associated acute respiratory distress syndrome
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 29 September 2026
Adipokines play an important role in immunometabolic regulation and systemic inflammation, processes profoundly disturbed in COVID-19. Leptin and adiponectin have attracted particular interest because of their opposing biological effects. However, most studies have relied on single time-point measurements, and data on serial adipokine dynamics in critically ill patients with COVID-19–associated acute respiratory distress syndrome (ARDS) remain limited. This study aimed to evaluate circulating leptin and adiponectin concentrations and their temporal changes during the first week of intensive care unit (ICU) treatment. This single-center prospective observational study included 75 adults with COVID-19–associated ARDS admitted to the medical ICU (MICU). Serum leptin and adiponectin concentrations were measured on day 1 and day 7 using enzyme-linked immunosorbent assays. Clinical data, including respiratory support, vasopressor use, comorbidities, and 28-day survival, were prospectively collected. The overall 28-day mortality was 38.7%. Leptin concentrations did not significantly change between day 1 and day 7 in any subgroup. In contrast, adiponectin demonstrated significant temporal changes. Among non-survivors, adiponectin levels decreased markedly during the first week of MICU treatment (p<0.001), whereas no significant change was observed in survivors. Similar declines were observed in patients requiring invasive mechanical ventilation and vasopressor therapy, while patients managed without these interventions showed increasing adiponectin concentrations. The leptin-to-adiponectin ratio showed a trend toward higher values in non-survivors but did not reach statistical significance. In COVID-19–associated ARDS patients, adiponectin demonstrated dynamic changes associated with clinical deterioration, whereas leptin remained relatively stable. These findings suggest that serial adiponectin measurements may have potential for monitoring short-term disease progression in critically ill patients and warrant confirmation in larger prospective studies.
Downloads
Coelho M, Oliveira T, Fernandes R. Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci 2013;9:191-200. DOI: https://doi.org/10.5114/aoms.2013.33181
Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue - an update. Horm Metab Res 2007;39:314-21. DOI: https://doi.org/10.1055/s-2007-976539
Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med 2020;8:1201-8. DOI: https://doi.org/10.1016/S2213-2600(20)30370-2
Flikweert AW, Kobold ACM, van der Sar-van der Brugge S, et al. Circulating adipokine levels and COVID-19 severity in hospitalized patients. Int J Obes 2023;47:126-37. DOI: https://doi.org/10.1038/s41366-022-01246-5
Flier JS, Ahima RS. Leptin physiology and pathophysiology: knowns and unknowns 30 years after its discovery. J Clin Invest. 2024;134:e174595. DOI: https://doi.org/10.1172/JCI174595
Pérez-Pérez A, Sánchez-Jiménez F, Vilariño-García T, Sánchez-Margalet V. Role of leptin in inflammation and vice versa. Int J Mol Sci 2020;21:5887. DOI: https://doi.org/10.3390/ijms21165887
Khoramipour K, Chamari K, Hekmatikar AA, et al. Adiponectin: structure, physiological functions, role in diseases, and effects of nutrition. Nutrients 2021;13:1180. DOI: https://doi.org/10.3390/nu13041180
Tonon F, Di Bella S, Giudici F, et al. Discriminatory value of adiponectin to leptin ratio for COVID-19 pneumonia. Int J Endocrinol 2022;2022:9908450. DOI: https://doi.org/10.21203/rs.3.rs-1254160/v1
Grewal T, Buechler C. Adipokines as diagnostic and prognostic markers for the severity of COVID-19. Biomedicines 2023;11:1302. DOI: https://doi.org/10.3390/biomedicines11051302
Di Filippo L, De Lorenzo R, Sciorati C, et al. Adiponectin to leptin ratio reflects inflammatory burden and survival in COVID-19. Diabetes Metab 2021;47:101268. DOI: https://doi.org/10.1016/j.diabet.2021.101268
La Cava A, Matarese G. The weight of leptin in immunity. Nat Rev Immunol 2004;4:371-9. DOI: https://doi.org/10.1038/nri1350
Larsson A, Lipcsey M, Hultström M, et al. Plasma leptin is increased in intensive care patients with COVID-19-an investigation performed in the PronMed-Cohort. Biomedicines 2021;10:4. DOI: https://doi.org/10.3390/biomedicines10010004
de Nooijer AH, Kooistra EJ, Grondman I, et al. Adipocytokine plasma concentrations reflect influence of inflammation but not body mass index (BMI) on clinical outcomes of COVID-19 patients: A prospective observational study from the Netherlands. Clin Obes 2023;13:e12568. DOI: https://doi.org/10.1111/cob.12568
Koch A, Weiskirchen R, Zimmermann HW, et al. Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators Inflamm 2010;2010:473540. DOI: https://doi.org/10.1155/2010/473540
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol 2011;11:85-97. DOI: https://doi.org/10.1038/nri2921
Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 2005;26:439-51. DOI: https://doi.org/10.1210/er.2005-0005
Barbalho SM, Minniti G, Miola VFB, et al. Organokines in COVID-19: a systematic review. Cells 2023;12:1349. DOI: https://doi.org/10.3390/cells12101349
Ismaiel A, Birkhahn L, Leucuta DC, et al. Are adipokines related to COVID-19 and its severity? A systematic review and meta-analysis. Med Pharm Rep 2024;97:120-31. DOI: https://doi.org/10.15386/mpr-2624
Perrotta F, Scialò F, Mallardo M, et al. Adiponectin, Leptin, and resistin are dysregulated in patients infected by SARS-CoV-2. Int J Mol Sci 2023;24:1131. DOI: https://doi.org/10.3390/ijms24021131
Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-69. DOI: https://doi.org/10.1007/s00125-003-1074-z
Oda N, Imamura S, Fujita T, et al. The ratio of leptin to adiponectin can be used as an index of insulin resistance. Metabolism 2008;57:268-73. DOI: https://doi.org/10.1016/j.metabol.2007.09.011
Manojlovic M, Ilincic B, Bojovic M, et al. Correlation between blood cell indices and adiponectin and leptin levels in COVID-19. Biomol Biomed 2025;25:693-700. DOI: https://doi.org/10.17305/bb.2024.11153
Pavel V, Räth U, Schmid S, et al. Serum adiponectin predicts COVID-19 severity. Biomedicines 2024;12:1043. DOI: https://doi.org/10.3390/biomedicines12051043
Ethics Approval
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.